DalsnaFinance › IPOs › Denali Therapeutics Inc.
Denali Therapeutics Inc. completed its initial public offering on NASDAQ on December 8, 2017, pricing at $18.00 a share.
| Ticker | DNLI |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | December 8, 2017 |
| Offering price | $18.00 |
| Shares offered | 13,888,888 |
| Total raised | $250M |
Denali Therapeutics Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.